Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Colchicine prophylaxis in pseudogout.

A Alvarellos, I Spilberg

    The Journal of Rheumatology
    |August 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Oral colchicine significantly reduced recurrent pseudogout attacks in patients. This prophylaxis demonstrated a 70% reduction in acute arthritis episodes, supporting its effectiveness.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    ILEOSTIM trial: a study protocol to evaluate the effectiveness of efferent loop stimulation before ileostomy reversal.

    Techniques in coloproctology·2023
    Same author

    IgG4-related orbital disease.

    Archivos de la Sociedad Espanola de Oftalmologia·2018
    Same author

    Pleuropulmonary involvement in patients with systemic lupus erythematosus from a Latin American inception cohort (GLADEL).

    Lupus·2017
    Same author

    Early discoid lupus erythematosus protects against renal disease in patients with systemic lupus erythematosus: longitudinal data from a large Latin American cohort.

    Lupus·2016
    Same author

    Late-onset systemic lupus erythematosus in Latin Americans: a distinct subgroup?

    Lupus·2014
    Same author

    Work instability in rheumatoid arthritis patients from Argentina: prevalence and associated factors.

    Rheumatology international·2014
    Same journal

    Clinical Features and Outcome Measures Across Still Disease (Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still Disease) Cohorts Worldwide: A Systematic Literature Review.

    The Journal of rheumatology·2026
    Same journal

    Bimekizumab Improves Health Status and Work Productivity, With Reduced Productivity Costs, to 3 Years in Axial Spondyloarthritis and Psoriatic Arthritis.

    The Journal of rheumatology·2026
    Same journal

    Qualitative Analysis of Physical Activity Engagement in Women with Self-Reported SLE: The Role of Symptoms, Healthcare Providers, and the Environment.

    The Journal of rheumatology·2026
    Same journal

    Changes in Transition Readiness in Youth with Arthritis and Lupus: A Longitudinal Study.

    The Journal of rheumatology·2026
    Same journal

    Distinct gut microbiomic and metabolomic signatures in knee and hip osteoarthritis.

    The Journal of rheumatology·2026
    Same journal

    GRAPPA 2025 Annual Meeting Report: Session on Geographic Variations in Psoriatic Arthritis/Psoriasis Care and Resource Limitations.

    The Journal of rheumatology·2026
    See all related articles

    Area of Science:

    • Rheumatology
    • Pharmacology

    Background:

    • Pseudogout, characterized by recurrent acute arthritis, significantly impacts patient quality of life.
    • Effective prophylactic treatments for pseudogout are crucial for managing chronic conditions.

    Purpose of the Study:

    • To evaluate the efficacy of oral colchicine as a prophylactic agent for recurrent pseudogout attacks.

    Main Methods:

    • A prospective study followed ten patients with recurrent pseudogout for one year.
    • Patients received oral colchicine 0.6 mg twice daily, with arthritis episodes recorded pre- and post-treatment.

    Main Results:

    • A significant reduction in acute arthritis episodes was observed, from 3.2 per patient per year to 1 per patient per year (p < 0.001).
    • Ninety percent of patients experienced clinical benefit from oral colchicine prophylaxis.

    Related Experiment Videos

    Conclusions:

    • Oral colchicine is an effective prophylactic treatment for reducing the frequency of pseudogout attacks.
    • The findings support the use of colchicine in managing patients with recurrent pseudogout.